SM-Youtube

Year	Number of Results
1945	1
1950	2
1951	1
1953	1
1954	2
1955	1
1957	1
1958	1
1959	1
1960	1
1961	1
1962	3
1963	1
1965	1
1966	1
1967	1
1970	1
1971	1
1972	9
1973	1
1974	1
1975	1
1977	2
1982	2
1985	2
1986	67
1987	392
1988	631
1989	1057
1990	1109
1991	1214
1992	1140
1993	1113
1994	1175
1995	1281
1996	1142
1997	956
1998	865
1999	820
2000	872
2001	928
2002	1010
2003	1127
2004	1245
2005	1301
2006	1545
2007	1531
2008	1545
2009	1595
2010	1742
2011	2031
2012	2137
2013	2307
2014	2421
2015	2689
2016	2428
2017	2239
2018	2253
2019	2231
2020	1939
2021	1621
2022	1011
2023	857
2024	550

Year

Number of Results

1945

1950

1951

1953

1954

1955

1957

1958

1959

1960

1961

1962

1963

1965

1966

1967

1970

1971

1972

1973

1974

1975

1977

1982

1985

1986

1987

392

1988

631

1989

1057

1990

1109

1991

1214

1992

1140

1993

1113

1994

1175

1995

1281

1996

1142

1997

956

1998

865

1999

820

2000

872

2001

928

2002

1010

2003

1127

2004

1245

2005

1301

2006

1545

2007

1531

2008

1545

2009

1595

2010

1742

2011

2031

2012

2137

2013

2307

2014

2421

2015

2689

2016

2428

2017

2239

2018

2253

2019

2231

2020

1939

2021

1621

2022

1011

2023

857

2024

550

Page 1

Enteral nutritional therapy for induction of remission in Crohn's disease.

Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Narula N, et al. Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD000542. doi: 10.1002/14651858.CD000542.pub3. Cochrane Database Syst Rev. 2018. PMID: 29607496 Free PMC article. Review.

Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.

Mohan BP, Fatima N, Khan SR, Kassab L, Chandan S, Asokkumar R, Valentine JF, Navaneethan U, Kochhar GS, Ma C, Jairath V, Singh S. Mohan BP, et al. Am J Gastroenterol. 2023 Nov 1;118(11):2084-2087. doi: 10.14309/ajg.0000000000002328. Epub 2023 May 19. Am J Gastroenterol. 2023. PMID: 37207296 No abstract available.

Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.

Mosli MH, MacDonald JK, Bickston SJ, Behm BW, Tsoulis DJ, Cheng J, Khanna R, Feagan BG. Mosli MH, et al. Inflamm Bowel Dis. 2015 May;21(5):1151-9. doi: 10.1097/MIB.0000000000000396. Inflamm Bowel Dis. 2015. PMID: 25844963 Review.

CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.

Mougiakakos D, Krönke G, Völkl S, Kretschmann S, Aigner M, Kharboutli S, Böltz S, Manger B, Mackensen A, Schett G. Mougiakakos D, et al. N Engl J Med. 2021 Aug 5;385(6):567-569. doi: 10.1056/NEJMc2107725. N Engl J Med. 2021. PMID: 34347960 No abstract available.

Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment.

Fu W, Hu Y, Lu G, Xu L, Gao L, Chen J, Chen L, Tang G, Ni X, Yang J. Fu W, et al. Ann Hematol. 2023 Feb;102(2):329-335. doi: 10.1007/s00277-023-05096-7. Epub 2023 Jan 12. Ann Hematol. 2023. PMID: 36633637

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'Haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV Jr, Marteau P, Munkholm P, Murdoch TB, Ordás I, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, Panes J, Bouguen G, O'Donnell S, Pariente B, Winer S, Hanauer S, Colombel JF. Peyrin-Biroulet L, et al. Am J Gastroenterol. 2015 Sep;110(9):1324-38. doi: 10.1038/ajg.2015.233. Epub 2015 Aug 25. Am J Gastroenterol. 2015. PMID: 26303131 Review.

Dietary and nutritional approaches for prevention and management of type 2 diabetes.

Forouhi NG, Misra A, Mohan V, Taylor R, Yancy W. Forouhi NG, et al. BMJ. 2018 Jun 13;361:k2234. doi: 10.1136/bmj.k2234. BMJ. 2018. PMID: 29898883 Free PMC article. Review.

Breaking the therapeutic ceiling in drug development in ulcerative colitis.

Alsoud D, Verstockt B, Fiocchi C, Vermeire S. Alsoud D, et al. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):589-595. doi: 10.1016/S2468-1253(21)00065-0. Epub 2021 May 19. Lancet Gastroenterol Hepatol. 2021. PMID: 34019798 Review.

Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.

Sandborn WJ, Rebuck R, Wang Y, Zou B, Adedokun OJ, Gasink C, Sands BE, Hanauer SB, Targan S, Ghosh S, de Villiers WJS, Colombel JF, Feagan BG, Lynch JP. Sandborn WJ, et al. Clin Gastroenterol Hepatol. 2022 Mar;20(3):578-590.e4. doi: 10.1016/j.cgh.2021.02.025. Epub 2021 Feb 19. Clin Gastroenterol Hepatol. 2022. PMID: 33618023 Free PMC article. Clinical Trial.

Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis.

Pray C, Wong ECL, Aruljothy A, Dulai PS, Marshall JK, Reinisch W, Narula N. Pray C, et al. Inflamm Bowel Dis. 2023 Aug 1;29(8):1263-1271. doi: 10.1093/ibd/izac210. Inflamm Bowel Dis. 2023. PMID: 36179118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

48,745 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Search Results

48,745 results

Results by year